Bolak Co Ltd
KRX:002760
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
991
1 145
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Operating Margin
Bolak Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| KR |
B
|
Bolak Co Ltd
KRX:002760
|
62.7B KRW |
-3%
|
|
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
81.8B USD |
16%
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
74.3B USD |
18%
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
9.3T JPY |
25%
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
28.4B CHF |
19%
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
242B CNY |
9%
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.7T INR |
15%
|
|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK |
25%
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
23.8B USD |
15%
|
|
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR |
15%
|
|
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
18.2B EUR |
4%
|
Bolak Co Ltd
Glance View
Bolak Co., Ltd. engages in the manufacture of food additives and pharmaceutical ingredients. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 139 full-time employees. The firm operates its business through two main divisions: food additives division and pharmaceutical ingredients division. Its food additives division engages in the manufacture of food flavors, food colors, botanical extracts, nutraceuticals, white emulsion, antioxidants, emulsifiers, bleaching agents, acidulant, sweetness and others. Its pharmaceutical ingredients division engages in the manufacture of pharmaceutical ingredients, including extract powers, fluid extracts, tinctures, protein concentrates, as well as calcium carboxymethyl cellulose (CMC). The firm distributes its products within domestic and to overseas markets.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Bolak Co Ltd's most recent financial statements, the company has Operating Margin of -2.5%.